Subscribe to our newsletter to receive the latest product updates and special offers

HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite
Theme 		Help
Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#81 / 200 Total
YTEN - Yield10 Bioscience Inc - Stock Price Chart
TickerYTEN [NASD]
CompanyYield10 Bioscience Inc
CountryUSA
IndustryAgricultural Inputs
Market Cap3.58MEPS (ttm)-50.04
P/E-EPS this Y58.52%
Forward P/E-EPS next Y-12.58%
PEG-EPS past 5Y45.25%
P/S59.73EPS next 5Y0.00%
P/B-EPS Q/Q59.37%
Dividend-Sales Q/Q-100.00%
Insider Own17.38%Inst Own94.49%
Insider Trans-38.96%Inst Trans-3.79%
Short Float1.72%EarningsApr 01/a
Analyst Recom3.00Target Price12.00
Avg Volume215.56K52W Range4.32 - 78.96
May-01-24 08:30AM Yield10 Bioscience Announces 1-for-24 Reverse Stock Split (GlobeNewswire) -8.44%
Apr-05-24 08:53AM Yield10 Bioscience, Inc. (NASDAQ:YTEN) Q4 2023 Earnings Call Transcript (Insider Monkey) +5.77%
Apr-02-24 06:34AM Q4 2023 Yield10 Bioscience Inc Earnings Call (Thomson Reuters StreetEvents) -42.57%
Apr-01-24 08:53PM YTEN Stock Earnings: Yield10 Bioscience Beats EPS for Q4 2023 (InvestorPlace)
04:01PM Yield10 Bioscience Announces Fourth Quarter and Full Year 2023 Financial Results (GlobeNewswire)
Mar-28-24 04:01PM Yield10 Bioscience to Announce Fourth Quarter and Full Year 2023 Financial Results and Host a Conference Call on Monday, April 1, 2024 (GlobeNewswire)
Mar-26-24 08:29AM Yield10 Bioscience Announces that the Plant Biosafety Office of the Canadian Food Inspection Agency has Cleared Genome-edited E3902 Camelina for Planting in Canada (GlobeNewswire)
Mar-21-24 11:05AM Why Is Yield10 (YTEN) Stock Up 117% Today? (InvestorPlace) +78.85%
08:29AM USDA-APHIS Determines that Yield10 Bioscience's Omega-3 Camelina Varieties May Be Planted and Bred in the United States (GlobeNewswire)
Feb-29-24 08:31AM Yield10 Bioscience Reports that Proprietary Varieties of Winter Camelina Show Tolerance to Commonly Used Herbicides in First Field Tests (GlobeNewswire) -7.25%
LYRA - Lyra Therapeutics Inc - Stock Price Chart
TickerLYRA [NASD]
CompanyLyra Therapeutics Inc
CountryUSA
IndustryBiotechnology
Market Cap245.67MEPS (ttm)-1.25
P/E-EPS this Y-2.25%
Forward P/E-EPS next Y6.47%
PEG-EPS past 5Y-21.63%
P/S146.23EPS next 5Y-1.60%
P/B3.17EPS Q/Q20.51%
Dividend-Sales Q/Q29.76%
Insider Own23.67%Inst Own59.55%
Insider Trans0.17%Inst Trans-0.19%
Short Float0.72%EarningsApr 30/a
Analyst Recom1.00Target Price12.00
Avg Volume368.41K52W Range2.36 - 6.79
Apr-30-24 09:56PM LYRA Stock Earnings: Lyra Therapeutics Misses EPS, Beats Revenue for Q1 2024 (InvestorPlace) +9.09%
05:30PM Lyra Therapeutics, Inc. (LYRA) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
04:04PM Lyra Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update (GlobeNewswire)
Apr-26-24 04:51PM Lyra Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire) -8.70%
Mar-28-24 07:08AM Lyra Therapeutics (LYRA) Soars 6.5%: Is Further Upside Left in the Stock? (Zacks)
Mar-25-24 08:50AM Lyra Therapeutics (LYRA) Is a Great Choice for 'Trend' Investors, Here's Why (Zacks)
Mar-23-24 05:31AM Lyra Therapeutics Inc (LYRA) Posts Year-End Financial Results, Aligns with EPS Projections (GuruFocus.com)
Mar-22-24 09:55AM Wall Street Analysts See a 101.81% Upside in Lyra Therapeutics (LYRA): Can the Stock Really Move This High? (Zacks)
Mar-21-24 10:54PM LYRA Stock Earnings: Lyra Therapeutics Beats EPS, Misses Revenue for Q4 2023 (InvestorPlace)
04:01PM Lyra Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update (GlobeNewswire)
NVCT - Nuvectis Pharma Inc - Stock Price Chart
TickerNVCT [NASD, RUT]
CompanyNuvectis Pharma Inc
CountryUSA
IndustryBiotechnology
Market Cap144.65MEPS (ttm)-1.40
P/E-EPS this Y-6.53%
Forward P/E-EPS next Y-16.85%
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B11.62EPS Q/Q16.86%
Dividend-Sales Q/Q-
Insider Own60.91%Inst Own8.68%
Insider Trans0.05%Inst Trans29.59%
Short Float11.84%EarningsMar 06/b
Analyst Recom1.00Target Price22.00
Avg Volume97.20K52W Range5.92 - 18.65
Apr-08-24 08:30AM Nuvectis Pharma's NXP900 Demonstrates Robust Activity in Non-Small Cell Lung Cancer Cell Lines (GlobeNewswire)
Apr-02-24 04:30PM 5 Healthcare Stocks to Buy for 2024 (InvestorPlace)
Mar-19-24 08:00AM Nuvectis Pharma Announces Upcoming Presentations at the 2024 American Association for Cancer Research Meeting (GlobeNewswire) -16.08%
Mar-15-24 08:00AM Nuvectis Pharma to Present at the 36th Annual Roth Conference (GlobeNewswire) +20.22%
Mar-14-24 09:00AM Nuvectis Pharma Announces Encouraging Preliminary Data from the NXP800 Phase 1b Clinical Trial in Platinum-Resistant ARID1a-Mutated Ovarian Cancer (GlobeNewswire) -5.08%
Mar-05-24 11:52PM NVCT Stock Earnings: Nuvectis Pharma Misses EPS for Q4 2023 (InvestorPlace)
08:31AM Nuvectis Pharma Inc (NVCT) Reports Increased Net Loss in FY 2023 Despite Clinical Progress (GuruFocus.com)
08:00AM Nuvectis Pharma, Inc. Reports Fiscal Year 2023 Financial Results and Business Highlights (GlobeNewswire)
Feb-09-24 08:32AM Correction: Nuvectis Pharma Announces Participation at Upcoming Investor Conferences (GlobeNewswire)
08:00AM Nuvectis Pharma Announces Participation at Upcoming Investor Conferences (GlobeNewswire)
UDMY - Udemy Inc - Stock Price Chart
TickerUDMY [NASD, RUT]
CompanyUdemy Inc
CountryUSA
IndustryEducation & Training Services
Market Cap1.60BEPS (ttm)-0.53
P/E-EPS this Y553.42%
Forward P/E40.74EPS next Y280.53%
PEG-EPS past 5Y-9.38%
P/S2.14EPS next 5Y-
P/B4.46EPS Q/Q61.68%
Dividend-Sales Q/Q11.57%
Insider Own50.21%Inst Own38.83%
Insider Trans-0.39%Inst Trans0.85%
Short Float4.93%EarningsMay 02/a
Analyst Recom1.58Target Price14.62
Avg Volume930.44K52W Range8.17 - 16.01
May-03-24 11:39AM Why Are Udemy (UDMY) Shares Soaring Today (StockStory)
04:21AM Udemy Inc (UDMY) Q1 2024 Earnings Call Transcript Highlights: Robust Growth Amidst Challenges (GuruFocus.com)
May-02-24 08:57PM UDMY Stock Earnings: Udemy Beats EPS, Beats Revenue for Q1 2024 (InvestorPlace)
07:00PM Udemy (UDMY) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks)
05:53PM Udemy Inc (UDMY) Q1 2024 Earnings: Surpasses Revenue Forecasts Despite Challenges (GuruFocus.com)
04:58PM Udemy's (NASDAQ:UDMY) Q1 Sales Top Estimates But Quarterly Guidance Underwhelms (StockStory)
04:05PM Udemy Reports First Quarter 2024 Results (GlobeNewswire)
May-01-24 03:06AM Udemy Earnings: What To Look For From UDMY (StockStory)
Apr-29-24 03:47PM 30 Small Business Ideas for Teens (Insider Monkey)
Apr-28-24 10:23PM 20 Cheapest Countries to Study Abroad (Insider Monkey)
GSIT - GSI Technology Inc - Stock Price Chart
TickerGSIT [NASD]
CompanyGSI Technology Inc
CountryUSA
IndustrySemiconductors
Market Cap74.89MEPS (ttm)-0.80
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S3.44EPS next 5Y10.00%
P/B1.89EPS Q/Q-6.42%
Dividend-Sales Q/Q-4.26%
Insider Own30.04%Inst Own17.12%
Insider Trans0.00%Inst Trans-1.54%
Short Float5.73%EarningsMay 02/a
Analyst Recom2.50Target Price8.00
Avg Volume592.12K52W Range1.51 - 9.80
May-03-24 06:13AM Q4 2024 GSI Technology Inc Earnings Call (Thomson Reuters StreetEvents) -19.78%
May-02-24 09:56PM GSIT Stock Earnings: GSI Technology Reported Results for Q4 2024 (InvestorPlace) -6.11%
05:45PM GSI Technology: Fiscal Q4 Earnings Snapshot (Associated Press Finance)
04:05PM GSI Technology, Inc. Reports Fourth Quarter and Fiscal Year 2024 Results and Business Update (GlobeNewswire)
Apr-18-24 08:55AM GSI Technology to Announce Fiscal Fourth Quarter and Year End 2024 Results on May 2, 2024 (GlobeNewswire)
Apr-02-24 08:55AM GSI Technology Announces Production Release of Two Gemini-I APU Servers (GlobeNewswire) +35.09%
Mar-31-24 12:15PM 10 AI Stocks That Will Skyrocket (Insider Monkey)
Jan-27-24 09:24AM GSI Technology, Inc. (NASDAQ:GSIT) Q3 2024 Earnings Call Transcript (Insider Monkey)
Jan-26-24 06:03AM Q3 2024 GSI Technology Inc Earnings Call (Thomson Reuters StreetEvents) -14.93%
Jan-25-24 04:48PM GSI Technology: Fiscal Q3 Earnings Snapshot (Associated Press Finance)
WAVE - Eco Wave Power Global AB ADR - Stock Price Chart
TickerWAVE [NASD]
CompanyEco Wave Power Global AB ADR
CountryIsrael
IndustryUtilities - Renewable
Market Cap17.48MEPS (ttm)-0.31
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-11.54%
P/S56.40EPS next 5Y-
P/B2.20EPS Q/Q25.45%
Dividend-Sales Q/Q-
Insider Own4.01%Inst Own0.57%
Insider Trans0.00%Inst Trans-
Short Float8.00%EarningsDec 05/a
Analyst Recom-Target Price-
Avg Volume1.08M52W Range1.01 - 4.94
Apr-11-24 09:05AM Eco Wave Power Signed a Contract with a Major Energy Company for a Demonstration to Harness Energy from the Waves at the Port of Los Angeles (PR Newswire)
Apr-08-24 09:07AM Eco Wave Power Chosen by a Major International Energy Company to Conduct Wave Energy Feasibility Studies for the U.S. Coastline (PR Newswire) +213.43%
Apr-03-24 08:59AM Eco Wave Power Global AB (publ) (NASDAQ:WAVE) Q4 2023 Earnings Call Transcript (Insider Monkey)
Apr-01-24 09:53PM WAVE Stock Earnings: Eco Wave Power Global Reported Results for Q4 2023 (InvestorPlace) +12.50%
09:20AM Eco Wave Power Announces 1,076% Revenue Increase, Investment Agreement with Major Energy Company for its LA Project, and Final License for the Construction of its First Commercial Project in Portugal (PR Newswire)
Mar-29-24 02:01PM Eco Wave Power Files its Annual Report on Form 20-F for the Year Ended December 31, 2023, and Announces Significant Progress in Full Year 2023 Financial and Operational Results (PR Newswire)
Feb-29-24 09:33AM Inna Braverman's Portrait will be Featured at the United Nations Vital Voices Art Exhibition for 'Women Leaders Powering the Global Goals' (PR Newswire)
Feb-20-24 10:08AM Eco Wave Power CEO Inna Braverman to Present at FII Priority Miami, Alongside Michael Dell, Mike Pompeo, Stephen Schwarzman, Jared Kushner, Gwyneth Paltrow, and other World Leaders (PR Newswire)
Feb-08-24 09:53AM Consortium including Eco Wave Power, Toshiba, Hitachi Energy, and UK Universities Secure 1.5 Million Grant to Develop Wave-Powered Microgrid for Island in Thailand (PR Newswire)
Jan-26-24 06:32AM 7 Renewable Energy Stocks to Avoid if You Are Looking to Grow Your Green (InvestorPlace) +8.50%
ALHC - Alignment Healthcare Inc - Stock Price Chart
TickerALHC [NASD, RUT]
CompanyAlignment Healthcare Inc
CountryUSA
IndustryHealthcare Plans
Market Cap1.26BEPS (ttm)-0.84
P/E-EPS this Y17.64%
Forward P/E-EPS next Y12.60%
PEG-EPS past 5Y-35.06%
P/S0.63EPS next 5Y-
P/B9.68EPS Q/Q-20.87%
Dividend-Sales Q/Q43.14%
Insider Own52.41%Inst Own40.89%
Insider Trans-0.10%Inst Trans-2.48%
Short Float5.17%EarningsMay 02/a
Analyst Recom2.17Target Price7.77
Avg Volume956.31K52W Range4.46 - 9.20
May-03-24 11:30AM UBS Adjusts Price Target on Alignment Healthcare to $6.50 From $8.50, Maintains Neutral Rating (MT Newswires) +26.05%
08:21AM Q1 2024 Alignment Healthcare Inc Earnings Call (Thomson Reuters StreetEvents)
May-02-24 08:59PM ALHC Stock Earnings: Alignment Healthcare Misses EPS, Beats Revenue for Q1 2024 (InvestorPlace)
07:00PM Compared to Estimates, Alignment Healthcare (ALHC) Q1 Earnings: A Look at Key Metrics (Zacks)
05:55PM Alignment Healthcare Surpasses Revenue Forecasts with Strong Q1 2024 Performance (GuruFocus.com)
05:35PM Alignment Healthcare (ALHC) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
04:32PM Alignment Healthcare: Q1 Earnings Snapshot (Associated Press Finance)
04:01PM Alignment Healthcare Reports First Quarter 2024 Results (GlobeNewswire)
Apr-30-24 08:00AM Alignment Healthcare to Present at Two Investor Conferences in May 2024 (GlobeNewswire)
Apr-25-24 10:01AM Earnings Preview: Alignment Healthcare (ALHC) Q1 Earnings Expected to Decline (Zacks)
GOVX - Geovax Labs Inc - Stock Price Chart
TickerGOVX [NASD]
CompanyGeovax Labs Inc
CountryUSA
IndustryBiotechnology
Market Cap3.72MEPS (ttm)-14.28
P/E-EPS this Y29.81%
Forward P/E-EPS next Y-
PEG-EPS past 5Y92.12%
P/S-EPS next 5Y-
P/B0.55EPS Q/Q-26.06%
Dividend-Sales Q/Q-
Insider Own1.69%Inst Own9.06%
Insider Trans82.72%Inst Trans-
Short Float0.28%EarningsFeb 29/a
Analyst Recom1.00Target Price90.00
Avg Volume39.97K52W Range1.38 - 11.54
Apr-04-24 12:30PM GeoVax Presents Data on GEO-CM04S1, a Next Generation Covid-19 Vaccine (GlobeNewswire)
Mar-28-24 09:00AM GeoVax to Present Data on GEO-CM04S1, a Next Generation Covid-19 Vaccine, at the World Vaccine Congress (GlobeNewswire) +8.11%
Mar-12-24 09:00AM GeoVax to Present at the 36th Annual Roth Conference (GlobeNewswire)
Mar-06-24 09:00AM GeoVax Achieves Milestone in Transition to Commercially Validated Manufacturing System (GlobeNewswire)
Mar-02-24 08:45AM GeoVax Labs, Inc. (NASDAQ:GOVX) Q4 2023 Earnings Call Transcript (Insider Monkey)
Feb-29-24 04:00PM GeoVax Reports 2023 Year-End Financial Results and Provides Business Update (GlobeNewswire)
Feb-22-24 09:00AM GeoVax to Report 2023 Financial Results and Provide Corporate Update on February 29, 2024 (GlobeNewswire)
Feb-19-24 09:00AM GeoVax to Present at the 2024 BIO CEO & Investor Conference (GlobeNewswire)
Feb-13-24 09:00AM GeoVax Announces Multiple Patent Issuances and Allowances (GlobeNewswire)
Feb-06-24 09:00AM GeoVax Reports Positive Interim Data From Phase 2 Clinical Trial of GEO-CM04S1 as a Universal Covid-19 Vaccine Booster (GlobeNewswire)
EBS - Emergent Biosolutions Inc - Stock Price Chart
TickerEBS [NYSE, RUT]
CompanyEmergent Biosolutions Inc
CountryUSA
IndustryDrug Manufacturers - Specialty & Generic
Market Cap203.06MEPS (ttm)-11.02
P/E-EPS this Y80.42%
Forward P/E-EPS next Y5.74%
PEG-EPS past 5Y-
P/S0.17EPS next 5Y-
P/B0.31EPS Q/Q104.73%
Dividend-Sales Q/Q81.95%
Insider Own4.05%Inst Own78.34%
Insider Trans0.00%Inst Trans-1.89%
Short Float11.77%EarningsMay 01/a
Analyst Recom3.00Target Price5.00
Avg Volume5.49M52W Range1.42 - 10.88
May-02-24 01:48PM Top Midday Gainers (MT Newswires) +70.98%
12:33PM Q1 2024 Emergent BioSolutions Inc Earnings Call (Thomson Reuters StreetEvents)
12:10PM MercadoLibre Stock Split: Will MELI Investors See Wishes Come True Today? (InvestorPlace)
11:27AM JPMorgan Just Raised Its Price Target on Carvana (CVNA) Stock (InvestorPlace)
11:13AM Emergent BioSolutions Layoffs 2024: What to Know About the Latest EBS Job Cuts (InvestorPlace)
10:38AM Emergent BioSolutions Inc. (NYSE:EBS) Q1 2024 Earnings Call Transcript (Insider Monkey)
08:00AM Top Premarket Gainers (MT Newswires)
07:58AM Why Is Emergent BioSolutions (EBS) Stock Up 57% Today? (InvestorPlace)
07:37AM Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday (InvestorPlace)
03:54AM Emergent BioSolutions Inc (EBS) (Q1 2024) Earnings Call Transcript Highlights: A Strong Start ... (GuruFocus.com)
AKTX - Akari Therapeutics Plc ADR - Stock Price Chart
TickerAKTX [NASD]
CompanyAkari Therapeutics Plc ADR
CountryUSA
IndustryBiotechnology
Market Cap9.00MEPS (ttm)-
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B-EPS Q/Q15.04%
Dividend-Sales Q/Q-
Insider Own0.40%Inst Own4.41%
Insider Trans0.00%Inst Trans-
Short Float0.01%EarningsApr 01/b
Analyst Recom1.00Target Price80.00
Avg Volume16.10K52W Range1.08 - 5.50
May-01-24 08:01AM Samir R. Patel, M.D. Appointed Interim CEO for Akari Therapeutics (GlobeNewswire) +10.39%
08:00AM Akari Therapeutics and Peak Bio Announce Portfolio Prioritization Plan for Combined Go-Forward Merger Entity (GlobeNewswire)
Apr-15-24 08:00AM Akari Therapeutics to Present PAS-Nomacopan Pre-Clinical Electroretinography (ERG) Data at ARVO 2024 (GlobeNewswire)
Apr-01-24 06:30AM Akari Therapeutics Reports Full-Year 2023 Financial Results and Recent Highlights (GlobeNewswire) -19.03%
Mar-08-24 04:38PM Kuehn Law Encourages VIVK, HES, SDPI, and AKTX Investors to Contact Law Firm (GlobeNewswire)
Mar-05-24 08:00AM Akari Therapeutics and Peak Bio Announce Definitive Agreement to Merge as Equals Creating an Expanded Pipeline That Features a Novel Antibody Drug Conjugate (ADC) Toolkit (GlobeNewswire)
Jan-02-24 08:00AM Akari Therapeutics Announces Existing Investors Support the Company Through a $2 Million Private Placement Financing (GlobeNewswire) -7.16%
Dec-14-23 08:00AM Akari Therapeutics to Present at Biotech Showcase 2024 (GlobeNewswire) +5.84%
Dec-01-23 08:00AM Akari Therapeutics Appoints Experienced Life Sciences Entrepreneur Samir R. Patel, M.D. to Board of Directors (GlobeNewswire) +9.49%
Nov-16-23 08:00AM Akari Therapeutics Presents Poster on Progress in Pre-Clinical Development of Long-Acting PAS-Nomacopan as a Potential Treatment for Geographic Atrophy at the 4th Annual Dry AMD Therapeutic Development Conference (GlobeNewswire)
1⋯4567891011121314⋯20
affiliate • advertise • toggle light mode • contact • privacy • help
do not sell my data • privacy settings
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2024 FINVIZ.com. All Rights Reserved.